Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. - sprookjes - yvandenbroek - TriplyDB

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

http://www.wikidata.org/entity/Q35072720

about

Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Subtype-specific therapy for autoimmune neuropathies?Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study.Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.Guillain-Barré syndrome: a century of progress.Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination.Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies Differential binding patterns of anti-sulfatide antibodies to glial membranes Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases

P2860

Q22251013-26EEA570-9368-4A1F-B581-51BB3FAE39BE Q26785669-EA8FACDD-044A-44A8-95C0-629C9D5D1ADB Q33980125-141618E1-431E-4EE3-95DE-B658E1987F53 Q35389058-C73EDCEE-9F5D-4125-980F-7374CA46AA1D Q35692197-1F32E672-CB33-4B03-82DB-044A131D2F3E Q36005389-07E19E54-7791-4BC1-A621-EACA8FE36512 Q36092674-DF5FFDE7-8589-4EE6-BF8B-B0864BAC1091 Q38300498-0EADCFFB-50D3-4110-AA10-ABAADB6E2EB9 Q38605062-96A48D82-4F6D-40CA-BE96-3F5CD56AF17B Q39011456-8250643A-E603-49A6-954D-666159481215 Q40281429-8A0104A5-0FA0-4D6C-842E-ECEBA8552904 Q41189967-B636591C-39E8-4B15-8356-5D890C6BC68C Q48282126-43813915-FE2C-4821-B964-15B1ED46C984 Q57300562-8166BC2B-D8A9-41BA-B06D-BF8D730BA0DC Q57464812-B33D900D-2ABD-41BB-80C6-4FC2E84F9A9C Q58749918-6D9E1307-492A-466F-BB07-4A28443368A8

P2860

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

http://www.wikidata.org/entity/Q35072720

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@ast

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@en

type

label

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@ast

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@en

prefLabel

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@ast

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@en

P1433

Q35072720-9D306884-7F31-4035-B58D-BD12D7510267

P1476

Q35072720-5CD05844-987E-4B40-A043-F2398D7244E4

P2093

Q35072720-4A601C7F-9E23-4112-B631-76BDB01C6E6B

Q35072720-6693AD1A-3014-406E-AE6A-44E4FF6F83D5

Q35072720-8218B451-AD20-478E-A8D9-8C207394A363

Q35072720-A3CDA201-FD48-4504-820D-A16D0DB556AF

Q35072720-A63BDF41-8237-44DB-9084-E73BF7664B7A

Q35072720-ADE974F3-13C1-4858-BB4E-DBDA20C6BAC6

P2860

Q35072720-0BB81D26-F3C7-42EB-B638-E75AFE43743C

Q35072720-2244ACCD-6C0F-4F46-A8FF-BC1A925AD203

Q35072720-2BDD51DF-11BC-4840-BE89-A83746EBBEF2

Q35072720-3104948E-1092-4194-8520-E2175463B304

Q35072720-3AC5DD1D-CF08-46DD-A111-35A8E4BBB3D9

Q35072720-4DDD0C6F-23C0-445C-BE11-017F62E9E549

Q35072720-50718B26-6497-4A89-AD6C-3ABC14BA596F

Q35072720-6573D50E-5193-44AD-8E0E-92DB883F60FF

Q35072720-71112F2C-2283-4C2D-9BE6-1F5216EBF162

Q35072720-832C25AA-2F7E-4A1B-A4C8-B25D8AEF98EC

P304

Q35072720-BEC0192E-F477-45D3-A8AF-C36BA9A46FC1

P31

Q35072720-4C30F220-CC91-4249-8DB0-4278D569D683

P356

Q35072720-615884D1-DCA2-4B59-ADBC-4EFA6EDACD4A

P407

Q35072720-EA84CA02-7F4A-4321-945E-EF23D7C5237A

P433

Q35072720-BA4B92E9-205C-46EB-BE48-9D1720FBBB3F

P478

Q35072720-C98FE9B4-BCF5-40AD-A563-7AA437D52C73

P50

Q35072720-6A02D14B-4593-42DB-888B-8445DA420E4C

Q35072720-9D5532EE-883F-46B1-98F7-5D17D043EC44

Q35072720-B79C53A5-4F05-43F0-9288-9F68C967C502

Q35072720-E1EBF2AF-318F-4DBB-9FD7-D050A51260AD

P577

Q35072720-31729CB7-A61C-4D1C-8BB9-9DD81B7F0A6F

P5875

Q35072720-B021AB8A-B8AF-4FD0-BDC0-565441481A06

P698

Q35072720-AE4EFCCA-7B88-4F6B-B179-3762756CAD00

P921

Q35072720-0F5FEA11-BA1C-42D4-A524-EB515218A79B

P932

Q35072720-375AEB35-66A2-44F5-B56C-B7D729EDA59A

P356

JOURNAL.PONE.0082337

P1433

P1476

Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.

@en

P2093

Christa Walgaard

http://www.w3.org/2001/XMLSchema#string

Gabriela Kalna

http://www.w3.org/2001/XMLSchema#string

Hugh J Willison

http://www.w3.org/2001/XMLSchema#string

Jan-Eric Mansson

http://www.w3.org/2001/XMLSchema#string

Kathryn M Brennan

http://www.w3.org/2001/XMLSchema#string

Robert K Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of current diagnostic criteria for Guillain-Barré syndrome

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

Diagnostic and classification criteria for the Guillain-Barré syndrome.

Selectin ligands.

Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis

Anti-ganglioside antibodies alter presynaptic release and calcium influx

Ganglioside mimicry and peripheral nerve disease.

Gangliosides as targets for autoimmune injury to the nervous system.

Anti-GM1 antibodies as a model of the immune response to self-glycans.

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

P304

e82337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0082337

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Carl S Goodyear

Pieter A van Doorn

P577

2013-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259395977

http://www.w3.org/2001/XMLSchema#string

P698

24358172

http://www.w3.org/2001/XMLSchema#string

P921

Guillain–Barré Syndrome

P932

3864991

http://www.w3.org/2001/XMLSchema#string